Loading viewer...
investor_presentation
Format: PDF investor_presentation
Halozyme Therapeutics presented its financial update and strategic outlook in January 2024, covering the company's proprietary ENHANZE® drug delivery technology platform, expected revenue growth, and guidance through 2028. The presentation details anticipated commercialization milestones, royalty expectations from partner collaborations, and plans for platform expansion including a high-volume auto-injector development.
earnings
10 Pages
investor_presentation
12 Pages
Restaurant Brands International
Sigma Additive Solutions SASI January 2023 Investor Presentation
investor_presentationinvestor_presentation
26 Pages
Sigma Additive Solutions, Inc.